J&J Vision announces availability of TECNIS Synergy IOL
Company introduces 'revolutionary' continuous-range-of-vision IOL
Priscilla Lynch
Published: Sunday, September 15, 2019
JOHNSON & Johnson Vision (JJV) invites ESCRS delegates to look at what the company describes as its “revolutionary” continuous-range-of-vision intraocular lens for patients with cataracts, which is now available in Europe, Australia and New Zealand.
“TECNIS Synergy™ IOL creates a new standard in presbyopia-correcting IOL technology, allowing patients to experience continuous high-contrast vision from far through near, even in low-light conditions,” a company spokesperson said.
“With TECNIS Synergy IOL, we have created our most advanced IOL solution yet, which gives patients the clear, continuous range of vision they want, day and night,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision.
“As ophthalmic pioneers, we continue to challenge ourselves on a daily basis to create solutions to the ever-changing needs of patients. Today, we stay true to our legacy of innovation with the introduction of TECNIS Synergy IOL, which we believe will redefine the industry standard for IOL quality and performance.”
Visit the JJV booth to learn more – Pavilion 7, Floor 7.2 Booth #E112
Tags: intraocular lens
Latest Articles
Towards a Unified IOL Classification
The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.